Onward Medical N.V.
ONWD.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.19 | -0.26 | 1.31 | -0.48 |
| FCF Yield | -13.80% | -34.10% | -14.44% | -7.21% |
| EV / EBITDA | -5.68 | -2.36 | -5.13 | -8.20 |
| Quality | ||||
| ROIC | -52.04% | -93.39% | -46.13% | -28.53% |
| Gross Margin | -1,094.81% | -2,785.34% | -583.75% | -189.28% |
| Cash Conversion Ratio | 0.89 | 0.89 | 0.80 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | -67.03% | -27.55% | 38.99% | 36.18% |
| Free Cash Flow Growth | 2.38% | -20.63% | -22.09% | -69.79% |
| Safety | ||||
| Net Debt / EBITDA | 1.35 | 0.37 | 0.88 | 2.68 |
| Interest Coverage | -18.27 | -25.46 | -21.14 | -5.10 |
| Efficiency | ||||
| Inventory Turnover | 9.02 | 131.20 | 773.00 | 13.63 |
| Cash Conversion Cycle | 1,058.63 | 174.00 | 161.36 | 45.02 |